全ゲノムシーケンシングの市場規模、シェア、動向分析レポート：製品・サービス別、タイプ別、ワークフロー別、用途別、最終用途別、地域別、セグメント予測、2025年～2030年

全ゲノムシーケンシング市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の全ゲノムシーケンシング市場規模は2030年までに66億7,000万米ドルに達し、2025年から2030年までのCAGRは22.17％で拡大すると予測されています。

市場成長の背景には、ゲノムマッピングプログラムへの全ゲノムシーケンシングの採用が増加していることと、希少遺伝性疾患を含む遺伝性疾患の有病率が増加していることがあります。2021年11月にニューイングランド・ジャーナル・オブ・メディシン誌に掲載された研究によると、全ゲノムシーケンシングは幅広い希少疾患の早期診断につながる可能性があり、精密医療への移行が報告されています。

さらに、WGSを利用した疾患の早期発見と治療のための研究開発への投資が増加していることも、市場の成長を促進すると予想されます。例えば、2023年2月、インドネシア政府とゲノム科学イニシアティブは、世界基金からの3,000万米ドルの投資を受け、COVID-19、結核、がん、遺伝性疾患、脳疾患、代謝性疾患などの疾患の早期発見と治療のための方法を実施する施設のネットワークを設立しました。

全ゲノムシーケンシングの応用範囲は広く、政府機関はヒト、植物、動物、微生物のゲノム配列決定のためにこれらの技術を採用しており、これが市場の成長を促進すると予想されます。例えば、米国食品医薬品局（FDA）は、各国で食中毒が発生した際に食中毒病原体を特定するためにこの手法を採用しました。FDAは、全ゲノムシーケンシング（WGS）プログラムのもと、2008年からこの技術を採用しています。パルスフィールドゲル電気泳動（PFGE）よりも効率的に食中毒病原体の全菌株を識別できるからです。

技術的進歩の高まりにより、様々な疾患や感染症を手頃な価格で正確かつタイムリーに診断できる革新的な全ゲノムシーケンシング製品が発売されています。これが市場の成長に寄与しています。例えば、2022年12月、LifeCell International Pvt. Ltd.はHaystackAnalyticsと共同で、結核感染の診断情報を特定し、薬剤耐性の課題に取り組むための全ゲノムシーケンシング検査であるTBを発売しました。

COVID-19の大流行により、この検査法に対する需要が世界的に高まり、SARS-CoV-2の迅速な特定と、大流行を管理するための可能な診断検査の開発が可能になった。そのため、世界中の政府が研究機関や企業セクターと協力して、SARS-CoV-2の同定と診断にこの方法を使用するようになった。いくつかの企業がSARS-CoV-2ウイルスのサーベイランスのためのゲノムサービスや迅速なソリューションを発表しています。例えば、QIAGENは、強力な変異体の同定、可能性のあるアウトブレイクの追跡、ワクチン研究や医薬品開発の進展のための全ゲノムシーケンシングサービスSARS-CoV-2サーベイランスを提供しています。

全ゲノムシーケンシング市場レポートハイライト

• 消耗品セグメントは2024年に61.56%の最大シェアを占めたが、これは幅広い消耗品が入手可能であることと、これらの製品の使用期間が短いため採用が増加していることによる。
• タイプ別では、大型全ゲノムシーケンシングセグメントが2024年の全ゲノムシーケンシング市場で77.32%の最大シェアを占めました。これは、がん腫瘍の解析や希少疾患の遺伝子変異の同定などの用途が拡大していることに起因しています。
• ワークフロー別では、シークエンシングセグメントが2024年に52.12%の最大市場シェアを占めました。これは、大手企業の関与の高まりと、プロセスの採用を後押しする新規製品の発売によるものです。
• アプリケーション別では、ヒト全ゲノムシーケンシングセグメントが2024年に62.91%のシェアで市場を独占しました。これは、希少な遺伝性疾患の蔓延が拡大していること、およびこれらの疾患の原因物質を特定するための研究開発への投資が増加していることに起因しています。
• 最終用途別では、学術・研究機関セグメントが48.72％の最大シェアで世界市場を独占しました。このセグメントの大きなシェアは、この分野で包括的な研究を行うために、これらの施設でハイスループット技術に対する需要が高まっていることに起因しています。
• 北米は2024年に51.34%の最大シェアを占めました。この大きなシェアは、この地域に確立されたヘルスケアシステムと製薬業界が存在し、臨床および研究目的の全ゲノムシーケンシングに対する大きな需要を生み出していることに起因しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助市場見通し
• 市場力学
  • 遺伝性疾患の罹患率の上昇
  • 遺伝子配列解析のコスト削減
  • ゲノムマッピングプログラムにおける全ゲノム配列解析の需要の高まり
• 市場抑制要因分析
  • ゲノム配列解析に関連する倫理的および法的課題
• 業界分析ツール
  • ポーターのファイブフォース分析
  • マクロ経済分析
  • COVID-19の影響分析

第4章 全ゲノムシーケンシング市場：製品とサービスのビジネス分析

• 製品およびサービスセグメントダッシュボード
• 世界の全ゲノムシーケンシング市場：製品とサービスの変動分析
• 2018年から2030年までの製品とサービス別の世界全ゲノムシーケンシング市場規模と動向分析
• 機器
• 消耗品
• サービス

第5章 全ゲノムシーケンシング市場：タイプビジネス分析

• タイプセグメントダッシュボード
• 世界の全ゲノムシーケンシング市場：型変動分析
• 世界の全ゲノムシーケンシング市場の規模と動向分析、タイプ別、2018～2030年
• 大規模全ゲノム配列解析
• 小規模全ゲノム配列解析

第6章 全ゲノムシーケンシング市場：ワークフロービジネス分析

• ワークフローセグメントダッシュボード
• 世界の全ゲノムシーケンシング市場：ワークフロー変動分析
• 世界の全ゲノムシーケンシング市場の規模と動向分析、ワークフロー別、2018～2030年
• プレシーケンシング
• シーケンシング
• データ分析

第7章 全ゲノムシーケンシング市場：用途ビジネス分析

• アプリケーションセグメントダッシュボード
• 世界の全ゲノムシーケンシング市場：用途変動分析
• 世界の全ゲノムシーケンシング市場の規模と動向分析、用途別、2018～2030年
• ヒト全ゲノム配列解析
• 植物の全エクソーム配列解析
• 動物の全エクソーム配列解析
• 微生物の全エクソーム配列解析

第8章 全ゲノムシーケンシング市場：最終用途ビジネス分析

• 最終用途セグメントダッシュボード
• 世界の全ゲノムシーケンシング市場：最終用途変動分析
• 世界の全ゲノムシーケンシング市場の規模と動向分析、最終用途別、2018～2030年
• 学術研究機関
• 病院・クリニック
• 製薬・バイオテクノロジー企業
• その他

第9章 全ゲノムシーケンシング市場：地域ビジネス分析

• 地域ダッシュボード
• 市場規模と予測および動向分析、2018年から2030年
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第10章 競合情勢

• 参入企業
• 戦略マッピング
• 企業市況分析、2024年
• 参入企業の概要
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc.
  • BGI
  • QIAGEN
  • Agilent Technologies
  • ProPhase Labs, Inc.（Nebula Genomics）
  • Psomagen
  • Azenta US, Inc.（GENEWIZ）

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Global whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 4 Global whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 5 Global whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 6 Global whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 7 Global whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 8 Global whole genome sequencing market, by region, 2018 - 2030 (USD Million)
• Table 9 North America whole genome sequencing market, by country, 2018 - 2030 (USD Million)
• Table 10 North America whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 11 North America whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 12 North America whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 13 North America whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 14 North America whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 15 U.S. whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 16 U.S. whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 17 U.S. whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 18 U.S. whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 19 U.S. whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 20 Canada whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 21 Canada whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 22 Canada whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 23 Canada whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 24 Canada whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 25 Mexico whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 26 Mexico whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 27 Mexico whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 28 Mexico whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 29 Mexico whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 30 Europe whole genome sequencing market, by country, 2018 - 2030 (USD Million)
• Table 31 Europe whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 32 Europe whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 33 Europe whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 34 Europe whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 35 Europe whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 36 UK whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 37 UK whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 38 UK whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 39 UK whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 40 UK whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 41 Germany whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 42 Germany whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 43 Germany whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 44 Germany whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 45 Germany whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 46 France whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 47 France whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 48 France whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 49 France whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 50 France whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 51 Italy whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 52 Italy whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 53 Italy whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 54 Italy whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 55 Italy whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 56 Spain whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 57 Spain whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 58 Spain whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 59 Spain whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 60 Spain whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 61 Denmark whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 62 Denmark whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 63 Denmark whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 64 Denmark whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 65 Denmark whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 66 Sweden whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 67 Sweden whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 68 Sweden whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 69 Sweden whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 70 Sweden whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 71 Norway whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 72 Norway whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 73 Norway whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 74 Norway whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 75 Norway whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 76 Asia Pacific whole genome sequencing market, by country, 2018 - 2030 (USD Million)
• Table 77 Asia Pacific whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 78 Asia Pacific whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 79 Asia Pacific whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 80 Asia Pacific whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 81 Asia Pacific whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 82 Japan whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 83 Japan whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 84 Japan whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 85 Japan whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 86 Japan whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 87 China whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 88 China whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 89 China whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 90 China whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 91 China whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 92 India whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 93 India whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 94 India whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 95 India whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 96 India whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 97 Australia whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 98 Australia whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 99 Australia whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 100 Australia whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 101 Australia whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 102 Thailand whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 103 Thailand whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 104 Thailand whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 105 Thailand whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 106 Thailand whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 107 South Korea whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 108 South Korea whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 109 South Korea whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 110 South Korea whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 111 South Korea whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 112 Latin America whole genome sequencing market, by country, 2018 - 2030 (USD Million)
• Table 113 Latin America whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 114 Latin America whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 115 Latin America whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 116 Latin America whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 117 Latin America whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 118 Brazil whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 119 Brazil whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 120 Brazil whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 121 Brazil whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 122 Brazil whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 123 Argentina whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 124 Argentina whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 125 Argentina whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 126 Argentina whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 127 Argentina whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 128 Middle East & Africa whole genome sequencing market, by country, 2018 - 2030 (USD Million)
• Table 129 Middle East & Africa whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 130 Middle East & Africa whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 131 Middle East & Africa whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 132 Middle East & Africa whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 133 Middle East & Africa whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 134 South Africa whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 135 South Africa whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 136 South Africa whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 137 South Africa whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 138 South Africa whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 139 Saudi Arabia whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 140 Saudi Arabia whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 141 Saudi Arabia whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 142 Saudi Arabia whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 143 Saudi Arabia whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 144 UAE whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 145 UAE whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 146 UAE whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 147 UAE whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 148 UAE whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 149 Kuwait whole genome sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 150 Kuwait whole genome sequencing market, by type, 2018 - 2030 (USD Million)
• Table 151 Kuwait whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 152 Kuwait whole genome sequencing market, by application, 2018 - 2030 (USD Million)
• Table 153 Kuwait whole genome sequencing market, by end use, 2018 - 2030 (USD Million)
• Table 154 Participant's overview
• Table 155 Financial performance
• Table 156 Key companies undergoing expansions
• Table 157 Key companies undergoing acquisitions
• Table 158 Key companies undergoing collaborations
• Table 159 Key companies launching new products/services
• Table 160 Key companies undertaking other strategies

List of Figures

• Fig. 1 Whole genome sequencing market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market snapshot
• Fig. 10 Segment snapshot
• Fig. 11 Competitive landscape snapshot
• Fig. 12 Parent market outlook
• Fig. 13 Related/ancillary market outlook
• Fig. 14 Whole genome sequencing market: Porter's analysis
• Fig. 15 Whole genome sequencing market: PESTLE analysis
• Fig. 16 Whole genome sequencing market: Product & service outlook and key takeaways
• Fig. 17 Whole genome sequencing market: Product & service movement analysis, 2024 - 2030
• Fig. 18 Global instruments market, 2018 - 2030 (USD Million)
• Fig. 19 Global consumables market, 2018 - 2030 (USD Million)
• Fig. 20 Global services market, 2018 - 2030 (USD Million)
• Fig. 21 Whole genome sequencing market: Type outlook and key takeaways
• Fig. 22 Whole genome sequencing market: Type movement analysis, 2024 - 2030
• Fig. 23 Global large whole genome sequencing market, 2018 - 2030 (USD Million)
• Fig. 24 Global small whole genome sequencing market, 2018 - 2030 (USD Million)
• Fig. 25 Whole genome sequencing market: Workflow outlook and key takeaways
• Fig. 26 Whole genome sequencing market: Workflow movement analysis, 2024 - 2030
• Fig. 27 Global pre-sequencing market, 2018 - 2030 (USD Million)
• Fig. 28 Global sequencing market, 2018 - 2030 (USD Million)
• Fig. 29 Global data analysis market, 2018 - 2030 (USD Million)
• Fig. 30 Whole genome sequencing market: Application outlook and key takeaways
• Fig. 31 Whole genome sequencing market: Application movement analysis, 2024 - 2030
• Fig. 32 Global human whole genome sequencing market, 2018 - 2030 (USD Million)
• Fig. 33 Global plant whole genome sequencing market, 2018 - 2030 (USD Million)
• Fig. 34 Global animal whole genome sequencing market, 2018 - 2030 (USD Million)
• Fig. 35 Global microbial whole genome sequencing market, 2018 - 2030 (USD Million)
• Fig. 36 Whole genome sequencing market: End use outlook and key takeaways
• Fig. 37 Whole genome sequencing market: End use movement analysis, 2024 - 2030
• Fig. 38 Global academic & research institutes market, 2018 - 2030 (USD Million)
• Fig. 39 Global hospitals & clinics market, 2018 - 2030 (USD Million)
• Fig. 40 Global pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
• Fig. 41 Global others market, 2018 - 2030 (USD Million)
• Fig. 42 Regional marketplace: Key takeaways
• Fig. 43 North America whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 44 U.S. key country dynamics
• Fig. 45 U.S. whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 46 Canada key country dynamics
• Fig. 47 Canada whole genome sequencing market, 2018 - 2030 (USD Million)
• Fig. 48 Mexico key country dynamics
• Fig. 49 Mexico whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 50 Europe whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 51 UK key country dynamics
• Fig. 52 UK whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 53 Germany key country dynamics
• Fig. 54 Germany whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 55 France key country dynamics
• Fig. 56 France whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 57 Italy key country dynamics
• Fig. 58 Italy whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 59 Spain key country dynamics
• Fig. 60 Spain whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 61 Denmark key country dynamics
• Fig. 62 Denmark whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 63 Sweden key country dynamics
• Fig. 64 Sweden whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 65 Norway key country dynamics
• Fig. 66 Norway whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 67 Asia-Pacific whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 68 Japan key country dynamics
• Fig. 69 Japan whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 70 China key country dynamics
• Fig. 71 China whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 72 India key country dynamics
• Fig. 73 India whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 74 Australia key country dynamics
• Fig. 75 Australia whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 76 Thailand key country dynamics
• Fig. 77 Thailand whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 78 South Korea key country dynamics
• Fig. 79 South Korea whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 80 Latin America whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 81 Brazil key country dynamics
• Fig. 82 Brazil whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 83 Argentina key country dynamics
• Fig. 84 Argentina whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 85 MEA whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 86 South Africa key country dynamics
• Fig. 87 South Africa whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 88 Saudi Arabia key country dynamics
• Fig. 89 Saudi Arabia whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 90 UAE key country dynamics
• Fig. 91 UAE whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 92 Kuwait key country dynamics
• Fig. 93 Kuwait whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 94 Key company categorization
• Fig. 95 Company market position analysis, 2024
• Fig. 96 Market participant categorization
• Fig. 97 Strategy framework

Whole Genome Sequencing Market Growth & Trends:

The global whole genome sequencing market size is projected to reach USD 6.67 billion by 2030, expanding at a CAGR of 22.17% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market growth can be attributed to the rising adoption of whole genome sequencing for genome mapping programs and the increasing prevalence of inherited disorders, including rare genetic disorders. According to the study published in the New England Journal of Medicine in November 2021, whole genome sequencing could lead to the early diagnosis of a wide range of rare diseases and a reported transition to precision medicine.

Furthermore, the growing investment in R&D for the early detection and treatment of disorders with the aid of WGS is expected to propel the growth of the market. For instance, in February 2023, the government of Indonesia and the Genome Science Initiative, with the aid of a USD 30 million investment from the Global Fund, established a network of facilities to perform the method for the early detection and treatment of disorders, including COVID-19, tuberculosis, cancer, genetic disorders, brain diseases, and metabolic disorders.

Whole genome sequencing has a wide range of applications, and government bodies are adopting these technologies for sequencing the genomes of humans, plant, animal, and microbes, which is expected to drive market growth. For instance, U.S. Food & Drug Administration (FDA) adopted the method to identify foodborne pathogens during foodborne disease outbreaks across the countries. The FDA has adopted this technology since 2008 under the Whole Genome Sequencing (WGS) program as it enables it to distinguish all strains of foodborne pathogens more efficiently than pulse-field gel electrophoresis (PFGE).

The rising technological advancements have led to the launch of innovative whole genome sequencing products that offer an affordable, accurate, and timely diagnosis of various diseases and infections. This is contributing to the growth of the market. For instance, in December 2022, LifeCell International Pvt. Ltd. collaborated with HaystackAnalytics to launch TB, a whole genome sequencing test to identify the diagnostic information on tuberculosis infections and tackle the drug resistance challenge.

The COVID-19 pandemic led to an increased demand for the method globally, which enabled the rapid identification of SARS-CoV-2 and the development of possible diagnostic tests to manage the outbreak. Hence, governments across the globe collaborated with research organizations and the corporate sector to use the method to identify and diagnose SARS-CoV-2. Several companies have launched genomic services and rapid solutions for the surveillance of the SARS-CoV-2 virus. For instance, QIAGEN offers the whole genome sequencing services SARS-CoV-2 surveillance for the identification of potent mutants, tracing of possible outbreaks, and advancement of vaccine research and drug development.

Whole Genome Sequencing Market Report Highlights:

• Consumables segment held the largest share of 61.56% in 2024, owing to the availability of a wide range of consumables and increased adoption of these products due to the shorter duration of use of these products
• By type, the large whole genome sequencing segment accounted for the largest share of 77.32% in the whole genome sequencing market in 2024. This can be attributed to the growing applications for analyzing cancerous tumors and identifying genetic variations in rare diseases
• By workflow, the sequencing segment held the largest market share of 52.12% in 2024, owing to the growing involvement of major companies and the launch of novel products to boost the adoption of the process
• By application, the human whole genome sequencing segment dominated the market in 2024 with a share of 62.91%. This can be attributed to the growing prevalence of rare inherited disorders and growing investment in R&D for the method to identify possible causative agents of these disorders
• By end-use, the academic & research institutes segment dominated the global market with the largest share of 48.72%. The large share of the segment can be attributed to the growing demand for high-throughput technologies at these facilities to conduct comprehensive research in this field
• North America held the largest market share of 51.34% in 2024. The large share can be attributed to the presence of a well-established healthcare system and pharmaceutical industry in the region, which has created a significant demand for whole genome sequencing for clinical and research purposes

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product & Service Segment
  • 1.2.2. Type Segment
  • 1.2.3. Workflow Segment
  • 1.2.4. Application Segment
  • 1.2.5. End Use Segment
• 1.3. Information Analysis
  • 1.3.1. Market Formulation & Data Visualization
• 1.4. Data Validation & Publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Rising prevalence of inherited disorders
  • 3.2.2. Decreasing costs for genetic sequencing
  • 3.2.3. Rising demand for whole genome sequencing for genome mapping programs
• 3.3. Market Restraint Analysis
  • 3.3.1. Ethical and legal challenges associated with genomic sequencing
• 3.4. Industry Analysis Tools
  • 3.4.1. Porter's Five Forces Analysis
  • 3.4.2. Macroeconomic Analysis
  • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Whole Genome Sequencing Market: Product & Service Business Analysis

• 4.1. Product & Service Segment Dashboard
• 4.2. Global Whole Genome Sequencing Market: Product & Service Movement Analysis
• 4.3. Global Whole Genome Sequencing Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
• 4.4. Instruments
  • 4.4.1. Instruments Market, 2018 - 2030 (USD Million)
• 4.5. Consumables
  • 4.5.1. Consumables Market, 2018 - 2030 (USD Million)
• 4.6. Services
  • 4.6.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Whole Genome Sequencing Market: Type Business Analysis

• 5.1. Type Segment Dashboard
• 5.2. Global Whole Genome Sequencing Market: Type Movement Analysis
• 5.3. Global Whole Genome Sequencing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 5.4. Large Whole Genome Sequencing
  • 5.4.1. Large Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
• 5.5. Small Whole Genome Sequencing
  • 5.5.1. Small Whole Genome Sequencing Market, 2018 - 2030 (USD Million)

Chapter 6. Whole Genome Sequencing Market: Workflow Business Analysis

• 6.1. Workflow Segment Dashboard
• 6.2. Global Whole Genome Sequencing Market: Workflow Movement Analysis
• 6.3. Global Whole Genome Sequencing Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
• 6.4. Pre-Sequencing
  • 6.4.1. Pre-Sequencing Market, 2018 - 2030 (USD Million)
• 6.5. Sequencing
  • 6.5.1. Sequencing Market, 2018 - 2030 (USD Million)
• 6.6. Data Analysis
  • 6.6.1. Data Analysis Market, 2018 - 2030 (USD Million)

Chapter 7. Whole Genome Sequencing Market: Application Business Analysis

• 7.1. Application Segment Dashboard
• 7.2. Global Whole Genome Sequencing Market: Application Movement Analysis
• 7.3. Global Whole Genome Sequencing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 7.4. Human Whole Genome Sequencing
  • 7.4.1. Human Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
• 7.5. Plant Whole Exome Sequencing
  • 7.5.1. Plant Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
• 7.6. Animal Whole Exome Sequencing
  • 7.6.1. Animal Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
• 7.7. Microbial Whole Exome Sequencing
  • 7.7.1. Microbial Market, 2018 - 2030 (USD Million)

Chapter 8. Whole Genome Sequencing Market: End Use Business Analysis

• 8.1. End use Segment Dashboard
• 8.2. Global Whole Genome Sequencing Market: End use Movement Analysis
• 8.3. Global Whole Genome Sequencing Market Size & Trend Analysis, by End use, 2018 to 2030 (USD Million)
• 8.4. Academic & Research Institutes
  • 8.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
• 8.5. Hospitals & Clinics
  • 8.5.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
• 8.6. Pharmaceutical & Biotechnology Companies
  • 8.6.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
• 8.7. Others
  • 8.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 9. Whole Genome Sequencing Market: Regional Business Analysis

• 9.1. Regional Dashboard
• 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 9.3. North America
  • 9.3.1. North America Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. Target Disease Prevalence
    • 9.3.2.3. Competitive Scenario
    • 9.3.2.4. Regulatory Framework
    • 9.3.2.5. Reimbursement Scenario
    • 9.3.2.6. U.S. Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Target Disease Prevalence
    • 9.3.3.3. Competitive Scenario
    • 9.3.3.4. Regulatory Framework
    • 9.3.3.5. Reimbursement Scenario
    • 9.3.3.6. Canada Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.3.4. Mexico
    • 9.3.4.1. Key Country Dynamics
    • 9.3.4.2. Target Disease Prevalence
    • 9.3.4.3. Competitive Scenario
    • 9.3.4.4. Regulatory Framework
    • 9.3.4.5. Reimbursement Scenario
    • 9.3.4.6. Mexico Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
• 9.4. Europe
  • 9.4.1. Europe Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.4.2. Germany
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Target Disease Prevalence
    • 9.4.2.3. Competitive Scenario
    • 9.4.2.4. Regulatory Framework
    • 9.4.2.5. Reimbursement Scenario
    • 9.4.2.6. Germany Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.4.3. UK
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Target Disease Prevalence
    • 9.4.3.3. Competitive Scenario
    • 9.4.3.4. Regulatory Framework
    • 9.4.3.5. Reimbursement Scenario
    • 9.4.3.6. UK Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.4.4. France
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Target Disease Prevalence
    • 9.4.4.3. Competitive Scenario
    • 9.4.4.4. Regulatory Framework
    • 9.4.4.5. Reimbursement Scenario
    • 9.4.4.6. France Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.4.5. Italy
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Target Disease Prevalence
    • 9.4.5.3. Competitive Scenario
    • 9.4.5.4. Regulatory Framework
    • 9.4.5.5. Reimbursement Scenario
    • 9.4.5.6. Italy Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.4.6. Spain
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Target Disease Prevalence
    • 9.4.6.3. Competitive Scenario
    • 9.4.6.4. Regulatory Framework
    • 9.4.6.5. Reimbursement Scenario
    • 9.4.6.6. Spain Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.4.7. Denmark
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Target Disease Prevalence
    • 9.4.7.3. Competitive Scenario
    • 9.4.7.4. Regulatory Framework
    • 9.4.7.5. Reimbursement Scenario
    • 9.4.7.6. Denmark Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.4.8. Sweden
    • 9.4.8.1. Key Country Dynamics
    • 9.4.8.2. Target Disease Prevalence
    • 9.4.8.3. Competitive Scenario
    • 9.4.8.4. Regulatory Framework
    • 9.4.8.5. Reimbursement Scenario
    • 9.4.8.6. Sweden Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.4.9. Norway
    • 9.4.9.1. Key Country Dynamics
    • 9.4.9.2. Target Disease Prevalence
    • 9.4.9.3. Competitive Scenario
    • 9.4.9.4. Regulatory Framework
    • 9.4.9.5. Reimbursement Scenario
    • 9.4.9.6. Norway Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.5.2. Japan
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Target Disease Prevalence
    • 9.5.2.3. Competitive Scenario
    • 9.5.2.4. Regulatory Framework
    • 9.5.2.5. Reimbursement Scenario
    • 9.5.2.6. Japan Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.5.3. China
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Target Disease Prevalence
    • 9.5.3.3. Competitive Scenario
    • 9.5.3.4. Regulatory Framework
    • 9.5.3.5. Reimbursement Scenario
    • 9.5.3.6. China Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.5.4. India
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Target Disease Prevalence
    • 9.5.4.3. Competitive Scenario
    • 9.5.4.4. Regulatory Framework
    • 9.5.4.5. Reimbursement Scenario
    • 9.5.4.6. India Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.5.5. South Korea
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Target Disease Prevalence
    • 9.5.5.3. Competitive Scenario
    • 9.5.5.4. Regulatory Framework
    • 9.5.5.5. Reimbursement Scenario
    • 9.5.5.6. South Korea Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.5.6. Australia
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Target Disease Prevalence
    • 9.5.6.3. Competitive Scenario
    • 9.5.6.4. Regulatory Framework
    • 9.5.6.5. Reimbursement Scenario
    • 9.5.6.6. Australia Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.5.7. Thailand
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Target Disease Prevalence
    • 9.5.7.3. Competitive Scenario
    • 9.5.7.4. Regulatory Framework
    • 9.5.7.5. Reimbursement Scenario
    • 9.5.7.6. Thailand Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
• 9.6. Latin America
  • 9.6.1. Latin America Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.6.2. Brazil
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Target Disease Prevalence
    • 9.6.2.3. Competitive Scenario
    • 9.6.2.4. Regulatory Framework
    • 9.6.2.5. Reimbursement Scenario
    • 9.6.2.6. Brazil Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.6.3. Argentina
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Target Disease Prevalence
    • 9.6.3.3. Competitive Scenario
    • 9.6.3.4. Regulatory Framework
    • 9.6.3.5. Reimbursement Scenario
    • 9.6.3.6. Argentina Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
• 9.7. MEA
  • 9.7.1. MEA Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.7.2. South Africa
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Target Disease Prevalence
    • 9.7.2.3. Competitive Scenario
    • 9.7.2.4. Regulatory Framework
    • 9.7.2.5. Reimbursement Scenario
    • 9.7.2.6. South Africa Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.7.3. Saudi Arabia
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Target Disease Prevalence
    • 9.7.3.3. Competitive Scenario
    • 9.7.3.4. Regulatory Framework
    • 9.7.3.5. Reimbursement Scenario
    • 9.7.3.6. Saudi Arabia Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.7.4. UAE
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. Target Disease Prevalence
    • 9.7.4.3. Competitive Scenario
    • 9.7.4.4. Regulatory Framework
    • 9.7.4.5. Reimbursement Scenario
    • 9.7.4.6. UAE Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Target Disease Prevalence
    • 9.7.5.3. Competitive Scenario
    • 9.7.5.4. Regulatory Framework
    • 9.7.5.5. Reimbursement Scenario
    • 9.7.5.6. Kuwait Whole Genome Sequencing Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Participant Categorization
• 10.2. Strategy Mapping
• 10.3. Company Market Position Analysis, 2024
• 10.4. Participant's Overview
  • 10.4.1. Illumina, Inc.
    • 10.4.1.1. Overview
    • 10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.1.3. Product & Service Benchmarking
    • 10.4.1.4. Strategic Initiatives
  • 10.4.2. Thermo Fisher Scientific, Inc.
    • 10.4.2.1. Overview
    • 10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.2.3. Product & Service Benchmarking
    • 10.4.2.4. Strategic Initiatives
  • 10.4.3. Oxford Nanopore Technologies
    • 10.4.3.1. Overview
    • 10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.3.3. Product & Service Benchmarking
    • 10.4.3.4. Strategic Initiatives
  • 10.4.4. Pacific Biosciences of California, Inc.
    • 10.4.4.1. Overview
    • 10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.4.3. Product & Service Benchmarking
    • 10.4.4.4. Strategic Initiatives
  • 10.4.5. BGI
    • 10.4.5.1. Overview
    • 10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.5.3. Product & Service Benchmarking
    • 10.4.5.4. Strategic Initiatives
  • 10.4.6. QIAGEN
    • 10.4.6.1. Overview
    • 10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.6.3. Product & Service Benchmarking
    • 10.4.6.4. Strategic Initiatives
  • 10.4.7. Agilent Technologies
    • 10.4.7.1. Overview
    • 10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.7.3. Product & Service Benchmarking
    • 10.4.7.4. Strategic Initiatives
  • 10.4.8. ProPhase Labs, Inc. (Nebula Genomics)
    • 10.4.8.1. Overview
    • 10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.8.3. Product & Service Benchmarking
    • 10.4.8.4. Strategic Initiatives
  • 10.4.9. Psomagen
    • 10.4.9.1. Overview
    • 10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.9.3. Product & Service Benchmarking
    • 10.4.9.4. Strategic Initiatives
  • 10.4.10. Azenta US, Inc. (GENEWIZ)
    • 10.4.10.1. Overview
    • 10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.10.3. Product & Service Benchmarking
    • 10.4.10.4. Strategic Initiatives